Amgen (AMGN) stock slid more than 4.5% at the start of Wednesday trading after the pharmaceutical giant reported the results of several drug trials.
Related Articles
Russia deputy prime minister says oil market is balanced thanks to OPEC+
Novak had graduated from being Russia's energy minister to deputy prime minister...
EURUSD Technical Analysis – The Euro falls to the lowest level since 2022
Fundamental OverviewOverall, we’ve seen a rangebound price action in the US Dollar...
USDCHF Technical Analysis – The USD gets a bid on weak Eurozone PMIs
Fundamental OverviewOverall, we’ve seen a rangebound price action in the US Dollar...
US Dollar surges to two-year high as Eurozone PMIs disappoint
The US Dollar (USD) jumps on Friday to its highest level in...
Leave a comment